STOCK TITAN

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PACIRA BIOSCIENCES, INC. (NASDAQ: PCRX) will present at the 2021 Barclays Global Healthcare Conference on March 9, 2021, at 10:55 AM ET. Interested parties can access the live audio from the company’s website's Events page, with a replay available for two weeks post-event. Pacira leads in non-opioid pain management solutions, notably with its long-acting local analgesic, EXPAREL®, launched in April 2012. The company aims to reduce opioid reliance, further emphasized by its acquisition of the iovera°® cryoanalgesia device in April 2019.

Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 Barclays Global Healthcare Conference at 10:55 AM ET on Tuesday, March 9, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

When will PCRX present at the Barclays Global Healthcare Conference?

Pacira BioSciences (PCRX) will present at the Barclays Global Healthcare Conference on March 9, 2021, at 10:55 AM ET.

How can I listen to the PCRX presentation live?

The live audio of Pacira's (PCRX) presentation can be accessed on the Events page of their website.

What is EXPAREL® and its significance for PCRX?

EXPAREL® is a long-acting local analgesic launched by Pacira (PCRX) in April 2012, aimed at improving non-opioid pain management.

What was the purpose of Pacira's acquisition of iovera°®?

Pacira BioSciences acquired the iovera°® system to enhance its portfolio in non-opioid pain management with controlled cryoanalgesia.

Where can I find the replay of the PCRX conference presentation?

A replay of Pacira's (PCRX) conference presentation will be available for two weeks after the event on their website.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

812.76M
45.12M
2.15%
114.41%
11.84%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA